Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment

BACKGROUND: This study aimed to determine the effect of Hyper-Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone (CVAD) in the treatment of acute lymphoblastic leukemia (ALL) patients and remission duration. MATERIALS AND METHODS: During a cross-sectional study in the Seyed Al-Shohada Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrzad, Valiollah, Ahmadifar, Abbas, Mahmoudzadeh, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991283/
https://www.ncbi.nlm.nih.gov/pubmed/29930921
http://dx.doi.org/10.4103/abr.abr_120_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991283/
https://www.ncbi.nlm.nih.gov/pubmed/29930921
http://dx.doi.org/10.4103/abr.abr_120_16

Ejemplares similares